Rocket


News + Filings
Transactions



SCHIMMEL PAUL

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
05/17/2023aTYR PHARMA INCLIFEGrantStock Option (right to buy)12k$2.52$30.2k 05/17/2023
05/10/2023aTYR PHARMA INCLIFEPurchaseCommon Stock200k$2.25$450kSee Footnote05/10/2023
04/26/2022aTYR PHARMA INCLIFEGrantRestricted Stock Units6k$0.00$0 04/26/2022
09/20/2021aTYR PHARMA INCLIFEPurchaseCommon Stock250k$8.00$2M 09/20/2021
09/20/2021aTYR PHARMA INCLIFEGiftCommon Stock250k$0.00$0 09/20/2021
09/20/2021aTYR PHARMA INCLIFEGiftCommon Stock250k$0.00$0See Footnote09/20/2021
05/18/2021aTYR PHARMA INCLIFEPurchaseCommon Stock50k$3.98$199kSee Footnote05/18/2021
04/28/2021aTYR PHARMA INCLIFEGrantStock Option (right to buy)1.4k$4.21$6k 04/28/2021
05/20/2020aTYR PHARMA INCLIFESaleCommon Stock8.4k$3.64$30.7kSee Footnote05/20/2020
05/06/2020aTYR PHARMA INCLIFEGrantStock Option (right to buy)1.4k$3.65$5.2k 05/06/2020
02/10/2020aTYR PHARMA INCLIFEPurchaseCommon Stock254k$4.25$1.1MSee Footnote02/10/2020
10/04/2019Forte Biosciences, Inc.TOCAGrantStock Option (right to buy)7.5k$0.64$4.8k 10/04/2019
07/01/2019ALNYLAM PHARMACEUTICALS, INC.ALNYGrantStock Option (right to buy)9k$72.01$648.1k 07/01/2019
05/29/2019Forte Biosciences, Inc.TOCAGrantStock option (right to buy)20k$4.22$84.4k 05/29/2019
05/08/2019aTYR PHARMA INCLIFEGrantStock Option (right to buy)20k$0.58$11.7k 05/08/2019
04/12/2019aTYR PHARMA INCLIFEGrantCommon Stock1.8M$0.54$1000kSee Footnote04/12/2019
11/26/2018aTYR PHARMA INCLIFEPurchaseCommon Stock147.2k$0.54$79.8kSee Footnote11/26/2018
09/04/2018aTYR PHARMA INCLIFEPurchaseCommon Stock20.7k$0.76$15.7kSee Footnote08/31/2018
08/31/2018aTYR PHARMA INCLIFEPurchaseCommon Stock22k$0.72$15.8kSee Footnote08/31/2018
08/30/2018aTYR PHARMA INCLIFEPurchaseCommon Stock89.3k$0.76$67.5kSee Footnote08/29/2018
08/29/2018aTYR PHARMA INCLIFEPurchaseCommon Stock75.1k$0.72$54.1kSee Footnote08/29/2018
06/21/2018Forte Biosciences, Inc.TOCAGrantStock option (right to buy)20k$8.98$179.6k 06/21/2018
06/20/2018ALNYLAM PHARMACEUTICALS, INC.ALNYGrantStock Option (right to buy)9k$105.26$947.3k 06/20/2018
05/18/2018aTYR PHARMA INCLIFEPurchaseCommon Stock150k$1.00$149.4kSee Footnote05/18/2018
05/15/2018aTYR PHARMA INCLIFEGrantStock Option (right to buy)20k$1.35$27k 05/15/2018
03/13/2018ALNYLAM PHARMACEUTICALS, INC.ALNYExerciseStock Option (right to buy)15k$59.25$888.8k 03/13/2018
03/13/2018ALNYLAM PHARMACEUTICALS, INC.ALNYExerciseStock Option (right to buy)2.8k$63.86$180.3k 03/13/2018
03/13/2018ALNYLAM PHARMACEUTICALS, INC.ALNYExerciseStock Option (right to buy)10k$30.09$300.9k 03/13/2018
03/13/2018ALNYLAM PHARMACEUTICALS, INC.ALNYSaleCommon Stock27.8k$150.00$4.2M 03/13/2018
08/31/2017aTYR PHARMA INCLIFEPurchaseWarrant to Purchase Common Stock35.4k$4.64$164.1kSee Footnote08/31/2017
08/31/2017aTYR PHARMA INCLIFEPurchaseCommon Stock94.3k$2.65$250kSee Footnote08/31/2017
06/02/2017ALNYLAM PHARMACEUTICALS, INC.ALNYGrantStock Option (right to buy)11.2k$71.99$809.9k 06/02/2017
05/09/2017aTYR PHARMA INCLIFEGrantStock Option (right to buy)20k$3.15$63k 05/09/2017
04/19/2017Forte Biosciences, Inc.TOCAConversionSeries G Preferred Stock25k$0.00$0By Paul Schimmel Prototype PSP Paul R. Schimmel, TTEE U/A dtd 01/01/1999 FBO Paul Schimmel04/19/2017
04/19/2017Forte Biosciences, Inc.TOCAConversionSeries F Preferred Stock28.4k$0.00$0By NFS/FMTC FBO Paul Schimmel Rollover IRA04/19/2017
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy